Evidence map›Paper›PMID 35452305›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Gene evolutionary trajectories in

Álvaro Chiner-Oms, Mariana G López, Miguel Moreno-Molina, Victoria Furió, Iñaki Comas

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The unique role ofmBio · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Genomic landscape ofNew microbes and new infections · 2025
    Article
  13. Article
  14. TheeLife · 2025
    Article
  15. Article
  16. Loss of theScience advances · 2025
    Article
  17. Article
  18. Chemical genetic interactions elucidate pathways controlling tuberculosis antibiotic efficacy during infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Molecular epidemiology ofJournal of clinical tuberculosis and other mycobacterial diseases · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Álvaro Chiner-OmsInstituto de Biomedicina de Valencia (IBV-CSIC), Valencia, 46010, Spain.ORCID 0000-0002-0463-0101
Mariana G LópezInstituto de Biomedicina de Valencia (IBV-CSIC), Valencia, 46010, Spain.
Miguel Moreno-MolinaInstituto de Biomedicina de Valencia (IBV-CSIC), Valencia, 46010, Spain.ORCID 0000-0003-0305-4445
Victoria FurióInstituto de Biomedicina de Valencia (IBV-CSIC), Valencia, 46010, Spain.
Iñaki ComasInstituto de Biomedicina de Valencia (IBV-CSIC), Valencia, 46010, Spain.ORCID 0000-0001-5504-9408
Instituto de Biomedicina de Valencia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic differences between different Mycobacterium tuberculosis complex (MTBC) strains determine their ability to transmit within different host populations, their latency times, and their drug resistance profiles. Said differences usually emerge through de novo mutations and are maintained or discarded by the balance of evolutionary forces. Using a dataset of ∼5,000 strains representing global MTBC diversity, we determined the past and present selective forces that have shaped the current variability observed in the pathogen population. We identified regions that have evolved under changing types of selection since the time of the MTBC common ancestor. Our approach highlighted striking differences in the genome regions relevant for host–pathogen interaction and, in particular, suggested an adaptive role for the sensor protein of two-component systems. In addition, we applied our approach to successfully identify potential determinants of resistance to drugs administered as second-line tuberculosis treatments.

Indexed as

Mycobacterium tuberculosisEvolution, MolecularGenome, BacterialMutationPhylogenySelection, GeneticSequence Analysis, DNAgenomicsMycobacterium tuberculosis complexpathogen evolution

Identifiers

PMID35452305
PMCPMC9173582
OpenAlexW4224285672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.